Antimetabolites.
Chu
E
E
Navy Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Johnston
P G
PG
Grem
J L
JL
Takimoto
C H
CH
Van Groeningen
C
C
Chabner
B A
BA
Allegra
C J
CJ
D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology; D004351:Drug Resistance; D005472:Fluorouracil / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D015122:Mercaptopurine / Q000494:pharmacology; D008727:Methotrexate / Q000493:pharmacokinetics / Q000494:pharmacology; D014740:Vidarabine / Q000031:analogs & derivatives / Q000494:pharmacology
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D015122:Mercaptopurine; D014740:Vidarabine; C024352:fludarabine; D005472:Fluorouracil; D008727:Methotrexate